Lab21 company

Lab21 is a rapidly growing healthcare diagnostics business. The company’s vision is of providing personalised diagnostic testing for disease identification, disease predisposition and personalised medicine to protect people from the health problems of tomorrow. We believe that ‘prevention is better than cure’ and aim to provide information that helps to protect people from their health problems of tomorrow.Lab 21 Clinical Laboratory supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services from its accredited facilities in Cambridge, UK. The Lab 21 team’s experience and know-how is coupled with a rapidly growing portfolio of molecular and viral diagnostics, plus next generation sequencing, pharmacogenetic and patient profiling tests, which all use cutting-edge technology. This unique combination adds value to pharmaceutical, diagnostic and biotech partners – and directly to clinicians or healthcare providers as they treat and monitor their patients.As we move towards truly personalised healthcare, the Lab 21 team contributes today – delivering high-quality information on drugs and patients that provides real clinical insight.
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Information Technology, Science and Engineering
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2005-01-01
Employees Number: 51-100
Funding Status: M&A
Acquisitions Number: 8
Investors Number: 2
Total Funding: $13.8M
Last Funding Type: Venture - Series Unknown

Visit Website
info@lab21.com
https://www.twitter.com/lab21cambridge
Register and Claim Ownership